Hasse diagrams for gapless SPT and SSB phases with non-invertible symmetries
Bhardwaj, L
Pajer, D
Schäfer-Nameki, S
Warman, A
SciPost Physics
volume 19
issue 4
(28 Oct 2025)
Suppression of pair beam instabilities in a laboratory analogue of blazar pair cascades
Arrowsmith, C
Miniati, F
Bilbao, P
Simon, P
Bott, A
Burger, S
Chen, H
Cruz, F
Davenne, T
Dyson, A
Efthymiopoulos, I
Froula, D
Goillot, A
Gudmundsson, J
Haberberger, D
Halliday, J
Hodge, T
Huffman, B
Iaquinta, S
Marshall, G
Reville, B
Sarkar, S
Schekochihin, A
Silva, L
Simpson, R
Stergiou, V
Trines, R
Vieu, T
Charitonidis, N
Bingham, R
Gregori, G
Proceedings of the National Academy of Sciences
volume 122
issue 45
(11 Nov 2025)
Introduction
Bays, M
Gavrilovich, M
Kirby, J
Model Theory
volume 3
issue 2
199-201
(01 Jan 2024)
Logic Tea in Oxford
Bays, M
Kirby, J
Model Theory
volume 3
issue 2
721-731
(01 Jan 2024)
Mon, 10 Nov 2025
16:00
16:00
C3
Calabi-Yau Threefolds, Counting Points and Physics
Eleonora Svanberg
(University of Oxford)
Abstract
For families of Calabi-Yau threefolds, we derive an explicit formula to count the number of points over $\mathbb{F}_{q}$ in terms of the periods of the holomorphic three-form, illustrated by the one-parameter mirror quintic and the 5-parameter Hulek-Verrill family. The formula holds for conifold singularities and naturally incorporates p-adic zeta values, the Yukawa coupling and modularity in the local zeta function. I will give a brief introduction on the physics motivation and how this framework links arithmetic, geometric and physics.
Zero-homogeneous and O(2)-equivariant critical points of the Oseen-Frank energy with multiple Frank constants
Nguyen, L
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
Hetherington, S
Hughes, A
Mosteller, M
Shortino, D
Baker, K
Spreen, W
Lai, E
Davies, K
Handley, A
Dow, D
Fling, M
Stocum, M
Bowman, C
Thurmond, L
Roses, A
Lancet (London, England)
volume 359
issue 9312
1121-1122
(Mar 2002)
Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programme.
Whitehead, J
Kelly, P
Zhou, Y
Stallard, N
Thygesen, H
Bowman, C
Pharmaceutical statistics
volume 8
issue 4
287-300
(Oct 2009)
Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?
Ramirez, C
Bowman, C
Maurage, C
Dubois, F
Blond, S
Porchet, N
Escande, F
Neuro-oncology
volume 12
issue 5
490-499
(14 May 2010)
Medical applications of haplotype-based SNP maps: learning to walk before we run.
Lai, E
Bowman, C
Bansal, A
Hughes, A
Mosteller, M
Roses, A
Nature genetics
volume 32
issue 3
353
(Nov 2002)